Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment

Pediatrics

Volumn 119, Issue 2, 2007, Pages

  Hauer, Julie M ^b,c   Wical, Beverly S ^a,c   Charnas, Lawrence ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c GILLETTE CHILDREN'S SPECIALTY HEALTHCARE   (United States)

Author keywords

Gabapentin; Irritability; Neurological impairment; Pain; Visceral hyperalgesia

Indexed keywords

AMITRIPTYLINE; GABAPENTIN; PROTON PUMP INHIBITOR; SALAZOSULFAPYRIDINE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; BRAIN ISCHEMIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; GASTRITIS; HUMAN; HYPERALGESIA; INFANT; INFANTILE SPASM; INTESTINAL DYSMOTILITY; IRRITABILITY; MALE; NEUROLOGIC DISEASE; NYSTAGMUS; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AMINES; ANALGESICS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; IRRITABLE MOOD; MALE; NERVOUS SYSTEM DISEASES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33947134850     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1609     Document Type: Article

References (25)

1. Tunnessen W Jr, Roberts K. Signs and Symptoms in Pediatrics. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1999
2. Breau LM, Camfield CS, McGrath PJ, Finley GA. The incidence of pain in children with severe cognitive impairments. Arch Pediatr Adolesc Med. 2003;157:1219-1226
3. Di Lorenzo C, Youssef NN, Sigurdsson L, Scharff L, Griffiths J, Wald A. Visceral hyperalgesia in children with functional abdominal pain. J Pediatr. 2001;139:838-843
4. Zangen T, Ciarla C, Zangen S, et al. Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers. J Pediatr Gastroenterol Nutr. 2003;37:287-293
5. Taketomo C, Hodding J, Kraus D, eds. Lexi Comp's Pediatric Dosage Handbook: Including Neonatal Dosing, Drug Administration, and Extemporaneous Preparations. 10th ed. Hudson, OH: Lexi-Comp, Inc; 2005
6. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al. Pain in children and adolescents: a common experience. Pain. 2000;87:51-58
7. Houlihan CM, O'Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol. 2004;46:305-310
8. Stallard P, Williams L, Lenton S, Velleman R. Pain in cognitively impaired, non-communicating children. Arch Dis Child. 2001;85:460-462
9. Breau LM, Camfield CS, McGrath PJ, Finley GA. Risk factors for pain in children with severe cognitive impairments. Dev Med Child Neurol. 2004;46:364-371
10. Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol. 2000;278:G670-G676
11. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol. 2005;39(4 suppl 3):S194-S203; discussion S210
12. Collins S. Putative therapeutic targets in the treatment of visceral hyperalgesia. Gut. 2004;53(suppl 2):ii19-ii21
13. Delafoy L, Gelot A, Ardid D, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut. 2006;55:940-945
14. Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gut. 2002;51(suppl 1):i29-i33
15. Beyak MJ, Vanner S. Inflammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels. Neurogastroenterol Motil. 2005;17:175-186
16. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology. 2000;119:1276-1285
17. Kang YM, Lamb K, Gebhart GF, Bielefeldt K. Experimentally induced ulcers and gastric sensory-motor function in rats. Am J Physiol Gastrointest Liver Physiol. 2005;288:G284-G291
18. Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain Dev. 1999;21:307-311
19. Schwarz SM, Corredor J, Fisher-Medina J, Cohen J, Rabinowitz S. Diagnosis and treatment of feeding disorders in children with developmental disabilities. Pediatrics. 2001;108:671-676
20. Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 2004;10:685-692
21. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63:959-965
22. Gilron I, Flatters SJ. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res Manag. 2006;11(suppl A):16A-29A
23. Gottrup H, Juhl G, Kristensen AD, et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology. 2004;101:1400-1408
24. Lee KJ, Kim JH, Cho SW. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22:981-988
25. Fioramonti J, Bueno L. Centrally acting agents and visceral sensitivity. Gut. 2002;51(suppl 1):i91-i95